Navegação Ciências da Saúde por Assunto "Lupus nephritis"

Resultados 1-6 de 6

    • Concomitance of IgM and IgG anti-dsDNA antibodies does not appear to associate to active lupus nephritis 

      Keiserman, Briele; Ronchetti, Maria Rita; Monticielo, Odirlei André; Keiserman, Mauro Waldemar; Staub, Henrique Luiz (2013) [Artigo de periódico]
      Previous reports proposed that the IgM anti-dsDNA antibody is protective for lupus nephritis. In this crosssectional study, we aimed to compare clinical features of systemic lupus erythematosus (SLE) patients positive for ...

    • NLRP3 inflammasome modulation by melatonin supplementation in chronic pristane-induced lupus nephritis 

      Bonomini, Francesca; Santos, Mariane dos; Veronese, Francisco José Veríssimo; Rezzani, Rita (2019) [Artigo de periódico]
      Lupus nephritis (LN) is a kidney inflammatory disease caused by systemic lupus erythematosus (SLE). NLRP3 inflammasome activation is implicated in LN pathogenesis, suggesting its potential targets for LN treatment. Melatonin, ...

    • Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis 

      Santos, Mariane dos; Bringhenti, Rafael Nazario; Rodrigues, Patrícia Garcia; Nascimento, Jonathan Fraportti do; Pereira, Sane Vianna; Zancan, Rafael; Monticielo, Odirlei André; Gasparin, Andrese Aline; Castro, Waldir Pedro de; Veronese, Francisco José Veríssimo (2015) [Artigo de periódico]
      Aim: Glomerular deposition of immune complexes and inflammation induce podocyte injury in lupus nephritis (LN). This study hypothesized that the severity of the histological lesions of LN affects podocyte-associated mRNAs ...

    • The landscape of systemic lupus erythematosus in Brazil : an expert panel review and recommendations 

      Klumb, Evandro Mendes; Scheinberg, Morton; Souza, Viviane Angelina de; Xavier, Ricardo Machado; Azevedo, Valderílio Feijó; McElwee, Elizabeth; Restrepo, Mariana Rico; Monticielo, Odirlei André (2021) [Artigo de periódico]
      Purpose: The objective of this review is to address the barriers limiting access to diagnosis and treatment of systemic lupus erythematosus (SLE) and lupus nephritis (LN) in Brazil, specifically for patients in the public ...

    • Tratamento da nefropatia lúpica severa : efeito da ciclosfosfamica endovenosa prolongada e intermitente 

      Morales, José Vanildo; Veronese, Francisco José Veríssimo; Weber, Raimar; Klamt, Charles L.; Berdichevski, Roberto Herz (2000) [Artigo de periódico]
      OBJETIVOS: A ciclofosfamida intravenosa é amplamente usada no tratamento da nefrite lúpica. Para analisar os desfechos a longo prazo, estudamos 54 pacientes tratados com ciclofosfamida no período compreendido entre 1989 e ...

    • Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis 

      Gasparin, Andrese Aline; Andrade, Nicole Pamplona Bueno de; Hax, Vanessa; Palominos, Penelope Esther; Siebert, Marina; Marx, Rômulo; Shaefer, P.; Veronese, Francisco José Veríssimo; Monticielo, Odirlei André (2020) [Artigo de periódico]
      Introduction: Vascular cell adhesion molecule-1 (VCAM-1) is involved in the progression of glomerular and tubulointerstitial injury in lupus nephritis (LN) and can be easily assessed in urine. The aim of this study was to ...